SAI
GILD icon

Savvy Advisors Inc’s Gilead Sciences GILD Stock Holding History

Savvy Advisors Inc’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.59M Buy
11,402
+2,596
+29% +$364K 0.04% 321
2025
Q4 		$1.08M Buy
8,806
+3,216
+58% +$391K 0.03% 349
2025
Q3 		$620K Buy
5,590
+995
+22% +$113K 0.03% 383
2025
Q2 		$509K Buy
4,595
+1,670
+57% +$178K 0.03% 345
2025
Q1 		$328K Buy
2,925
+589
+25% +$60.8K 0.03% 371
2024
Q4 		$216K Buy
+2,336
New +$210K 0.03% 415

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Savvy Advisors Inc's GILD Position: Q1 2026 in Review

Savvy Advisors Inc increased its Gilead Sciences (GILD) stake by 29% in Q1 2026, buying an estimated $364K and bringing the position to 11,402 shares worth $1.59M. The position accounts for 0.04% of the portfolio, ranked #321.

Savvy Advisors Inc first reported a position in GILD in Q4 2024 and has held it in 6 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Savvy Advisors Inc held 11,402 shares of Gilead Sciences worth $1.59M as of Q1 2026.
  • Savvy Advisors Inc bought 2,596 Gilead Sciences shares in Q1 2026, an estimated $364K.
  • Gilead Sciences made up 0.04% of Savvy Advisors Inc's portfolio in Q1 2026, its #321 holding.
  • Savvy Advisors Inc first reported a position in Gilead Sciences in Q4 2024 and has held it in 6 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Savvy Advisors Inc's 13F filing for Q1 2026, filed 11 May 2026.